| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC5669 | Zwm026 | Novel multi-target inhibitor, harboring selectivity of inhibiting EGFR T790M sparing wild-type EGFR |
|
| DCC5670 | Zxh-1-161 Featured | Novel Selective Degrader of GSPT1 |
|
| DCC5671 | Zx-j-19j | Novel inhibitor of Cyclophilin J (CyPJ) PPIase, demonstrating remarkable inhibition of tumor cell growth, comparable to CsA but much stronger than 5-fluorouracil |
|
| DCC5672 | Zx-j-19l | Novel inhibitor of Cyclophilin J (CyPJ) PPIase, demonstrating remarkable inhibition of tumor cell growth, comparable to CsA but much stronger than 5-fluorouracil |
|
| DCC5673 | Zxx2-77 | Cyclooxygenase-1 inhibitor |
|
| DCC5674 | Zydpla1 | Novel next generation orally active DPP-4 inhibitor to treat Type 2 Diabetes |
|
| DCC5675 | Zyj-25e | Novel histone deacetylase inhibitor (HDACi) with potent oral antitumor activities |
|
| DCC5676 | Zyj-34c | Novel histone deacetylase inhibitor (HDACi) with potent oral antitumor activities |
|
| DCC5677 | Zyj-34v | Oral active histone deacetylase inhibitor with potent antitumor activity |
|
| DCC5678 | Zyz-803 | Novel slow H2S-NO-releasing hybrid, attenuating cardiac dysfunction after heart failure |
|
| DC73867 | EN171 Featured | EN171 covalently targets both C38 and C96 on 14−3−3 to enhance 14−3−3 interactions with ERα, YAP, and TAZ, leading to impaired estrogen receptor and Hippo pathway transcriptional activity. |
|
| DC73868 | CNB-001 | CNB-001 is a pyrazole derivative of curcumin with neuroprotective properties, inhibits extracellular Aβ toxicity in hippocampal neurons with EC50 of 400 nM. |
|
| DC73869 | DDQ | DDQ is a small molecule inhibitor of binding sites of Amyloid beta (Aβ) and Drp1, reduces interaction between Aβ and Drp1, shows anti-aging effects. |
|
| DC73870 | MeSC-04 | MeSC-04 is a potent α-Syn amyloid formation inhibitor, reduces the number and size of amyloid fibrils in vitro. |
|
| DC73871 | NPT200-11 | NPT200-11 is an orally bioavailable and brain penetrating alpha-synuclein (ASYN) misfolding and aggregation inhibitor. |
|
| DC73872 | SRI-42667 | SRI-42667 is a selective small-molecule Tau-SH3 interaction inhibitor with IC50 of 0.91 uM (Tau-FynSH3 interaction), prevents amyloid-β toxicity and network hyperexcitability. |
|
| DC73873 | CC-8977 | CC-8977 is a hgihly potent, selective inhibitor of calcium/calmodulin-dependent kinase kinase II (CaMKK2) with binding IC50 of 7 nM. |
|
| DC73874 | SMP-114 | SMP-114 (Rimacalib) is a potent, specific and orally available CaMKII inhibitor with potential for treatment of rheumatoid arthritis. |
|
| DC73875 | BMS-332 | BMS-332 (BMS332) is a potent, selective dual DGKα/ζ inhibitor with IC50 of 9/8 nM respectively. |
|
| DC73876 | BMS-684 | BMS-684 (BMS684) is a potent, selective inhibitor of diacylglycerol kinase α(DGKα) with IC50 of 15 nM, weakly inhibist DGKβ and DGKγ, does not inhibit other DGK lipid kinases. |
|
| DC73877 | JNJ-3790339 | JNJ-3790339 is a potent and selective inhibitor of diacylglycerol kinase α (DGKα), demonstrates similar cytotoxicity in GBM and melanoma cells as ritanserin. |
|
| DC73878 | GRL018-21 | GRL018-21 is a highly selective, potent, and non-covalent GRK5 inhibitor with IC50 of 10 nM, >100,000-fold selectivity over GRK2. |
|
| DC73879 | (3S) ALG-05 | (3S) ALG-05 is a potent pan-inhibitor of gut microbia tryptophan-indole-lyases (TILs, E.C. 4.1.99.1), exhibits inhibitory activity across TILs with Ki of 7-11 uM. |
|
| DC73880 | (R)-HTS-3 | (R)-HTS-3 is a small-molecule inhibitor of LPCAT3, an integral membrane acyltransferase in the Lands cycle responsible for generating C20:4 phospholipids. |
|
| DC73881 | (R)-SKBG-1 Featured | (R)-SKBG-1 is a covalent small molecule ligand of RNA-binding protein NONO, engages NONO Cys145 and suppress an array of cancer-relevant genes and impair cancer cell proliferation. |
|
| DC73882 | (S)-CKi-1 Featured | (S)-CKi-1 is a selective, covalent inhibitor of creatine kinases (CKs), inhibits recombinant creatine kinase B (CKB) phosphotransfer activity with IC50 of 0.6 uM, depletes creatine phosphagen energetics in cells. |
|
| DC73883 | (S)-IBD3540 | (S)-IBD3540 is a potent, gut-restricted and orally active small molecule glutamate carboxypeptidase II (GCPII) inhibitor with IC50 of 4 nM, demonstrates anti-colitis activity in both acute and chronic mouse colitis models. |
|
| DC73884 | 2,5-pyridinedicarboxylic acid | 2,5-pyridinedicarboxylic acid is a highly selective D-dopachrome tautomerase (D-DT, MIF2) inhibitor with Ki of 17.2 uM, 79-fold selectivity over MIF, effectively blocks the D-DT-induced activation of CD74. |
|
| DC73885 | 2-TCPA | 2-TCPA is a potent, specific inhibitor of carbamoyl-phosphate synthetase, aspartate transcarbamoylase, and dihydroorotase (CAD), suppresses SARS-CoV-2 replication in Caco-2 cells with IC50 of 2.36 uM. |
|
| DC73886 | 3-mercaptopicolinic acid hydrochloride | SKF-34288 (3-Mercaptopicolinic acid) hydrochloride is an orally active phosphoenolpyruvate carboxykinase (PEPCK, PCK) inhibitor with Ki of 2-9 uM, an inhibitor of gluconeogenesis. |
|
